These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11411202)

  • 41. Cognitive dysfunction: an important extrahepatic manifestation of hepatitis C infection?
    Kennelly SP
    Postgrad Med J; 2013 Aug; 89(1054):431-2. PubMed ID: 23840068
    [No Abstract]   [Full Text] [Related]  

  • 42. ANALYSIS OF HEPATITIS C VIRUS INFECTION MODELS WITH HEPATOCYTE HOMEOSTASIS.
    Reluga TC; Dahari H; Perelson AS
    SIAM J Appl Math; 2009 Jan; 69(4):999-1023. PubMed ID: 19183708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hepatitis C virus alters the structure and function of peroxisomes].
    Martin de Fourchambault E; Rouillé Y
    Med Sci (Paris); 2024 May; 40(5):399-401. PubMed ID: 38819270
    [No Abstract]   [Full Text] [Related]  

  • 44. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
    Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
    J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mathematical modeling of HCV infection and treatment.
    Dahari H; Shudo E; Ribeiro RM; Perelson AS
    Methods Mol Biol; 2009; 510():439-53. PubMed ID: 19009281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
    Aberle JH; Formann E; Steindl-Munda P; Weseslindtner L; Gurguta C; Perstinger G; Grilnberger E; Laferl H; Dienes HP; Popow-Kraupp T; Ferenci P; Holzmann H
    J Clin Virol; 2006 May; 36(1):24-31. PubMed ID: 16483838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral dynamics in hepatitis C.
    Kershenobich D; Henonin CH
    Isr Med Assoc J; 2001 May; 3(5):360-3. PubMed ID: 11411202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
    Bartenschlager R
    Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New kinetic models for the hepatitis C virus.
    Perelson AS; Herrmann E; Micol F; Zeuzem S
    Hepatology; 2005 Oct; 42(4):749-54. PubMed ID: 16175615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evasion of host immune surveillance by hepatitis C virus: potential roles in viral persistence.
    Moorman JP; Joo M; Hahn YS
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):189-94. PubMed ID: 11478392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.
    Rosen HR
    Liver Transpl; 2003 Nov; 9(11):S35-43. PubMed ID: 14586893
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.